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Background: Glucose-6-phosphate dehydrogenase (G6PD) is a metabolic enzyme involved in the pentose phosphate
pathway, its especially important in red blood cell metabolism. Glucose-6-phosphate dehydrogenase deficiency is an
X-linked recessive hereditary disease characterised by abnormally low levels of G6PD. About 400 million people
worldwide have a deficiency of this enzyme. The remarkable geographic correlation of G6PD deficiency distribution
with historical endemicity patterns of malaria has led to suggestions that the two could be linked. Some studies have
concluded that G6PD deficiency confers resistance to malaria.
Objective: To determine the prevalence of G6PD deficiency, and determine its relationship with prevalence and
incidence of P. falciparum infection among children in Uganda.
Methods: This was longitudinal study involving 245 children, 135 were actively followed up for 12 months. G6PD status
was assessed for using PCR-RFLP method. A thick smear was done to determine presence of plasmodium trophozoites
and parasite densities.
Results: A total of 245 children between 6 months and 9 years were recruited. Of these 46.5% were males. Overall
prevalence for the X-linked G6PD A- mutation was; 79.59% wild type, 12.65% heterozygous and 7.76% homozygous or
hemizygous. Among the males 14% were hemizygous. At baseline, 40.8% had asymptomatic P falciparum infection.
There was no statistically significant difference in prevalence and incidence rates of malaria infection among the
different G6PD genotypes with prevalence among heterozygous, homozygous, and wild type being 29%, 42.6%
and 43% respectively (p = 0.11) and incidence among heterozygous and wild type being 0.56 and 0.52 episodes/year
(p = 0.5). The heterozygous G6PD A- females had a lower parasite density compared to the wild type (2505 vs 941
parasites/μL; P = 0.024).
Conclusions: This study showed that 20.41% of the population in this part of Uganda carry the G6PD A-mutation,
within the range of 15-32% seen in other parts of Africa. P. falciparum infection incidence and prevalence rates are
similar among the G6PD genotypes though, once infected, P. falciparum parasite densities are lowest among G6PD
A- heterozygous females. This suggests differences in P. falciparum infection rates and severity of disease could be
mediated by differences in parasite densities among the different G6PD genotypes.* Correspondence: kaddumark@yahoo.co.uk
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Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme
that is present in the cytoplasm of all cells of the body.
It plays a pivotal role in the generation of nicotinamide
adenine di-phosphosphate-H (NADPH) in cells. G6PD
is involved in the first step of the Pentose Phosphate
Shunt, where it catalyzes the oxidation of Glucose-6-
Phosphate to 6-Phosphogluconolactone. This is the first
step in a process that results in formation of NADPH
and eventually reduced glutathione (GSH).
G6PD deficiency is the most frequent inherited human
enzyme defect in red blood cells. G6PD is an X-linked
enzyme. Mutations in the G6PD gene result in different
levels of enzyme activity, consequently causing a wide
range of biochemical and clinical phenotypes [1,2]. Up to
140 different mutations have been identified in different
parts of the world, each resulting in varying degrees of
enzyme deficiency [1,3]. The World Health Organization
has defined the different G6PD variants according to the
enzyme levels, genotype and the severity of hemolysis. The
clinical expression of G6PD deficiency varies from severe
enzyme deficiency to increased enzyme activity (class I to
class V). The commonest clinical patterns are; 1) neonatal
jaundice, 2) congenital hemolytic anemia, 3) drug-induced
hemolysis and 4) favism [1,2].
It is estimated that up to 400 million people worldwide
have this deficiency. The high incidence of G6PD defi-
ciency in Africa is likely due to malaria. The striking
geographic correlation of G6PD deficiency distribution
with the historical endemicity patterns of malaria has led
to suggestions that two are linked. Studies to confirm
this link have been equivocal [4-10]; this might be due
to the different methods and diagnostic tests. Most studies
in Africa show that the two X-linked mutations A376G
and G202A cause between 85-100% of G6PD deficiency
seen in Africa, and that both mutations have to be present
for the enzyme deficiency to occur. In this study the
G202A mutation was assessed for [9,11].
This was a sub-study of an ongoing cohort study of
children for potential malaria vaccine trials. The ob-
jective of this sub-study was to determine the prevalence
of G6PD deficiency and determine its relationship with P.
falciparum infection prevalence (asymptomatic infection),
incidence and parasite density.
Methods
This study was a longitudinal study conducted starting
October 1st 2008 to 31st December 2009. Field methods:
A total of 245 children between 6 months and 9 years
where recruited by stratified random sampling from Iganga
district in eastern Uganda. Majority of the inhabitants are
from the ethnic Basoga tribe. Only one child per household
was recruited to minimize clustering and if there was more
than one potential subject in the household then a ballotwas used. After informed consent, blood samples were col-
lected. The children were followed up for 1 year with 114
and 135 in active and passive arms respectively. Allocation
to each arm was done randomly. Those in the active arm
were visited at home fortnightly and had a blood smear and
body temperature taken on each visit. They were also asked
to report to the study clinic if any illness occurred. Those
in passive arm were asked to report to the study clinic in
case of any illness. All study participants who developed
malaria were treated with Artemether/lumefantrine in
standard doses as per Uganda treatment guidelines.Laboratory methods
DNA was analyzed for the presence for the presence of
one of the common G6PD mutations G→A at nt 202
using Polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP) method. DNA was extracted
from a prepared buffy coat using E.Z.N.A blood DNA kits
(Omega Bio-Tek Inc. Doraville. GA 30362. USA). PCR
amplification was done using primers F – 5’-CCA CCA
CTG CCC CTG TGA CCT-3’ and R- 5’-GGC CCT GAC
ACCACC CAC CTT-3’. Details of the PCR-RFLP process
are described elsewhere [9].
Thick blood smears were done to assess for malaria
parasites using equal volumes of venous blood and stained
with 2% Giemsa. All the blood smears were then double
read independently by trained laboratory technicians. Where
results between the two expert microscopists were dis-
cordant, a third microscopist re-read the blood slide and
the majority decision was accepted as the final result.
Parasite densities were determined from thick blood
smears by examining the smears under × 100 objective.
The average number of parasites/oil immersion field was
then determined and the parasite density in number/μl
was calculated by multiplying the average number of para-
sites per field by a microscope factor of 1/0.002. Samples
collected at baseline were used to determine prevalence
and G6PD status of the participants.Data analysis
STATA statistical software version 10.0 (StataCorp, College
Station, TX) was used for analysis. Descriptive statis-
tics were expressed as proportions and means ± SD
(Range). For the relationship between G6PD status and
P. falciparum infection, two by two tables were used to
calculate Chi squared tests and odds ratio with 95%
confidence intervals. The t test for unequal variances was
used for comparison between malaria parasite density and
different genotypes. Spearman’s correlation coefficient was
used to test the relationship between parasite density and
age. Incidence rates and rate ratios were calculated from
the follow up data. A p-value < 0.05 was taken as statisti-
cally significant.
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Results
A total of two hundred forty five (245) children were re-
cruited into the study. Of the children approached, 97.5%
of those eligible were enrolled. One hundred and fourteen
subjects (46.5%) were male. The age ranged from six (6)
months to nine (9) years with a mean age of 4.4 (±2.3)
years. The majority 232 (95%) of the study population
were of the Basoga ethnic group which is the predominant
tribe in Iganga. Ninety two percent (225/245) of the study
participants reported to have used an Insecticide Treated
Net in the night preceding the interview. The average
household size was five inhabitants. Of the children re-
cruited into the study the median family position was
third. Fifteen percent (20/134) did not complete the an-
ticipated follow up period of one year due to migration
out of the study site. Overall twenty four percent (50/245)
of the study participants had a G6PD A-mutation. The
distribution of the prevalence of G6PD A genotypes
among the study participants are shown in Table 1.
Overall among those with the mutation, heterozygous
females were highest at 12.6% (31/245) prevalence followed
by hemizygous males 6.6% (16/303) and lowest was homo-
zygous females 1.2% (3/245) Figure 1.
This prevalence of asymptomatic P falciparum infection
was 40.8% (100 of 245) among the children recruited at
the baseline. The P. falciparum gametocyte carriage rate
was 22% (55/245) among the study participants at baseline
Table 2.
During the one year follow up, a total of 64 cumulative
malaria episodes of symptomatic malaria were recorded
among the 245 study participants. 55.4% (31/56) had
only one malaria episode, 28.5% (16/56) had two, 12.5%
(7/56) suffered three episodes while 3.6% (2/56) had four
malaria episodes during the one year follow up period.
The relationship between G6PA mutations and presence
of malaria parasites was assessed for by comparing propor-
tions using chi square test. There was a lower prevalence of
P. falciparum infection among the G6PD A- heterozygous
females compared to the wild type and homozygous but
this was not statistically significant; 29.03%, 42.6%, and 43%
respectively OR 0.55, (95% CI 0.24- 1.24, p = 0.11). The
percentage of G6PD A hemizygous males harboring




Females 97 (74%)those with the wild type G6PD (42.6% versus 42.1%,
OR 0.98 (95% CI 0.37 – 2.55), p = 0.9.
Malaria incidence rates were 0.56 episodes/year for
G6PD wild-type, and 0.52 episodes/year for G6PD A −
female heterozygote’s (p = 0.5) and there was only 1
homozygous male followed up actively. Of the children
who had P. falciparum infection, the geometric mean para-
site density was 2285 (range 250 – 41150) parasites/μl.
There was a statistically significant difference in mean
parasite densities between the wild types and the het-
erozygote’s, with lower parasite densities among the female
G6PD A- heterozygote’s compared to wild type with;
941 parasites/μl versus 2505 parasites/μl respectively with
P = 0.024, using a t test with unequal variances). There was
a weak negative correlation between malaria parasite
density and age, with r = − 0.33 (p = 0.0008).
Discussion
It is now apparent that genetic influence of malaria
susceptibility in humans is very important. Understanding
these interactions may influence the different interventions
especially with drug therapy for malaria. This is important
in clinical trials especially vaccine trials as this would im-
pact on the outcome endpoints. The prevalence of G6PD
was not known in our study site.
This study reveals that the prevalence of the G6PD A-
genotype is high in this part of Uganda at 20.4%. This
rate is within the range of 15-30% that has been found
elsewhere in sub-Saharan Africa [5,12-14] and comparable
to that found in Uganda, although the populations were of
different ethnicity [9]. This high prevalence raises concern
and need for caution within this study population when
using drugs which cause oxidative stress on RBCs such
as Primaquine or other compounds that can spark off
hemoglobinuria.
Of the 245 children studied, 40.82% were found to
have asymptomatic P falciparum infection. This rate
however should be interpreted in context of the period
of recruitment that coincided with a period of prolonged
dry weather as this would result in lower infection rates.
The rate of asymptomatic P. falciparum infections sug-
gests that this is an area of moderate malaria transmission.
Higher asymptomatic P. falciparum infection rates of
greater than 70% are seen in areas of high transmission
and rates of lower than 10% are seen in areas of low trans-
mission [11,15-17]. Asymptomatic P falciparum infection
probably plays an important role in maintaining malariaong the 245 study children
HETEROZYGOUS HOMO/HEMIZYGOUS
31 (12.65%) 19 (7.76%)
NA 16 (14%)
31 (23.7%) 3 (2.3%)
Figure 1 Showing the final product after PCR-RFLP gel electrophoresis. The photo shows the molecular marker 100 bp column bands,
211 bp bands for wild type; 211 bp, 124 bp and 87 bp bands for heterozygous samples and 87 bp and 124 bp for homozygous samples. The
columns 12 and 16 had the control samples.
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that helps perpetuate malaria transmission [16,17]. In
addition it may be associated with anemia in infected
children and more morbidity in those with sickle cell
anemia [15,18,19]. The only possible benefit is that
asymptomatic P falciparum infection might play an
important role in the development of malaria specific
immunity [19-21].
The lack of a significant difference in the both preva-
lence and incidence rates of infection among the different
G6PD genotypes suggests this mutation might not in-
fluence susceptibility to malaria. On the other hand,
the significant difference in parasite densities among
the heterozygous females and the wild types points
towards the fact that this mutation might influence
disease severity as parasite density is a known factor in
disease severity. This is in keeping with longitudinal
studies on the relationship between malaria and G6PD
polymorphisms that have shown that G6PD A- individuals
have lower incidence of severe malaria [8,9,14]. These
findings support the hypothesis that differences in malaria
severity among the different G6PD polymorphisms is due
to the impact of G6PD status on parasite densities
[20-23]. The findings on differences in prevalence is not
consistent with the a similar study conducted in Gabon
that showed that female heterozygous children were
protected against asymptomatic malaria with rates of
39% versus 67% (p = 0.03) compared to those with wild
type G6PD alleles [13]. However in the Gabonese study,
the more sensitive PCR was used to diagnose asymptomatic
infection and the participant age group was 7 to 19 years
while the children were followed up for 4 days to excludeTable 2 Table showing baseline thick blood smear results
for P. falciparum trophozoites and gametocytes
Malaria blood smear result Frequency (%)
Negative for trophozoites 145 (59.2%)
Positive for trophozoites 100 (40.8%)
Positive for Gametocytes* 55 (22.5%)
*Note: 2 participants had gametocytes without trophozoites.later development of symptoms. We did not find a sig-
nificant difference in incidence rates in this population
among the different G6PD polymorphisms. Considering
that other studies have showed that numerous other
genetic polymorphisms have an association with malaria
including; sickle cell trait and disease, blood group, ni-
tric oxide synthase, Tumor Necrosis Factor (TNF) α
promoter, haptoglobin, α-thalasemia, intercellular adhe-
sion molecule–1, and RANTES, the interactions involving
all these genotypes may be complex. This might necessi-
tate a large longitudinal study to further clarify on the bio-
logical and statistical interactions of all these genetic
polymorphisms with malaria susceptibility [3,9,12,13,22].
Limitations of this study include; Use of microscopy to
determine P falciparum asymptomatic infection could
have resulted in a lower prevalence as a PCR assay would
have been more accurate for this and only one host factor
that influences susceptibility to malaria i.e. G6PD status
was studied hence no multivariate analysis was done.
Conclusions
This study showed that 20.41% of the population in this
part of Uganda carry the G6PD A-mutation, within the
range of 15-32% seen in other parts of Africa. P. falciparum
infection incidence and prevalence rates are similar among
the G6PD genotypes though, once infected, P. falciparum
parasite densities are lowest among G6PD A- heterozygous
females. This suggests differences in P. falciparum infection
rates and severity of disease could be mediated by dif-
ferences in parasite densities among the different G6PD
genotypes. Given this high prevalence of the G6PD A-
mutation, screening for this mutation is warranted in
the work up of patients with acute hemolytic anemia in
this population. It has also shown that up to 40% of
otherwise healthy children harbor malaria parasites. It
is likely that the interaction between malaria and these
polymorphisms is complex thus a clear impact for one
of them might not be easily discernible from a single
cross sectional study. A large longitudinal study to
assess the role and interaction of each of these is
necessary.
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